Secrecy or transparency? The future of regulatory trial data.
作者信息
Wieseler Beate, McGauran Natalie
机构信息
Institute for Quality and Efficiency in Health Care, Cologne, Germany
Institute for Quality and Efficiency in Health Care, Cologne, Germany.
出版信息
CMAJ. 2017 Feb 6;189(5):E185-E186. doi: 10.1503/cmaj.161088. Epub 2016 Nov 14.
Abstract
摘要
相似文献
1
Secrecy or transparency? The future of regulatory trial data.保密还是透明？监管试验数据的未来。
CMAJ. 2017 Feb 6;189(5):E185-E186. doi: 10.1503/cmaj.161088. Epub 2016 Nov 14.
2
Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act.临床试验透明度与试验和实验研究透明度法案。
Contemp Clin Trials. 2014 Mar;37(2):219-24. doi: 10.1016/j.cct.2014.01.001. Epub 2014 Jan 15.
3
4
Doctor's oath to secrecy and psychiatric patient.医生对保密和精神科患者的誓言。
Coll Antropol. 1997 Jun;21(1):251-8.
5
Associations among solicitation, relationship quality, and adolescents' disclosure and secrecy with mothers and best friends.青少年向母亲和最好的朋友寻求帮助、关系质量以及披露与保密行为之间的关联。
J Adolesc. 2015 Aug;43:193-205. doi: 10.1016/j.adolescence.2015.05.016. Epub 2015 Jul 2.
6
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.医学研究中的保密法与保密性：改善公众获取药物安全数据的途径
Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483.
7
Disclosure and secrecy in adolescent-parent relationships.青少年与父母关系中的披露与保密
Child Dev. 2006 Jan-Feb;77(1):201-17. doi: 10.1111/j.1467-8624.2006.00865.x.
8
You may be held liable for unauthorized disclosure of patients' medical records.你可能会因未经授权披露患者的医疗记录而承担法律责任。
Mod Hosp. 1946 Apr;66(4):77.
9
Secrets and disclosure in donor conception.供体受孕中的秘密与披露。
Sociol Health Illn. 2018 Jan;40(1):188-203. doi: 10.1111/1467-9566.12633. Epub 2017 Nov 16.
10
Are secret relationships hot, then not? Romantic secrecy as a function of relationship duration.秘密关系是火辣的，还是不火辣的？作为关系持续时间函数的浪漫秘密。
J Soc Psychol. 2010 Nov-Dec;150(6):668-88. doi: 10.1080/00224540903365547.
引用本文的文献
1
Audit of data redaction practices in NICE technology appraisals from 1999 to 2019.1999 年至 2019 年英国国家卫生与临床优化研究所技术评估中数据编辑实践的审核。
BMJ Open. 2021 Oct 6;11(10):e051812. doi: 10.1136/bmjopen-2021-051812.
2
Recent advances in pharmacological management of urinary incontinence.尿失禁药物治疗的最新进展
F1000Res. 2017 Dec 19;6:2148. doi: 10.12688/f1000research.12593.1. eCollection 2017.
3
Increasing the transparency of clinical data.提高临床数据的透明度。
CMAJ. 2017 Mar 27;189(12):E473. doi: 10.1503/cmaj.170271.
本文引用的文献
1
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.度洛西汀治疗压力性尿失禁的利弊分析：临床研究报告的荟萃分析
CMAJ. 2017 Feb 6;189(5):E194-E203. doi: 10.1503/cmaj.151104. Epub 2016 Nov 14.
2
North American regulatory agencies can and should make clinical trial data publicly available.北美监管机构能够且应该公开临床试验数据。
CMAJ. 2016 Feb 2;188(2):96-97. doi: 10.1503/cmaj.150679. Epub 2015 Oct 13.
3
New European legislation on clinical trials is published.欧洲关于临床试验的新法规发布了。
BMJ. 2014 Jun 18;348:g4102. doi: 10.1136/bmj.g4102.
4
The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer.欧洲药品管理局文件获取政策的头两年：不再保密。
JAMA Intern Med. 2013 Mar 11;173(5):380-2. doi: 10.1001/jamainternmed.2013.3838.
5
The imperative to share clinical study reports: recommendations from the Tamiflu experience.分享临床研究报告的必要性：来自达菲经验的建议。
PLoS Med. 2012;9(4):e1001201. doi: 10.1371/journal.pmed.1001201. Epub 2012 Apr 10.
6
Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications.文件类型对临床药物试验报告质量的影响：注册报告、临床研究报告和期刊出版物的比较。
BMJ. 2012 Jan 3;344:d8141. doi: 10.1136/bmj.d8141.
7
Opening up data at the European Medicines Agency.欧洲药品管理局开放数据。
BMJ. 2011 May 10;342:d2686. doi: 10.1136/bmj.d2686.
Zotero 插件